1 – 125 of 125
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.
(
- Contribution to journal › Article
-
Mark
Early diagnostic value of Bcl-3 localization in colorectal cancer.
(
- Contribution to journal › Article
-
Mark
Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.
(
- Contribution to journal › Article
- 2014
-
Mark
Breastfeeding in relation to risk of different breast cancer characteristics.
(
- Contribution to journal › Article
-
Mark
Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer.
(
- Contribution to journal › Article
-
Mark
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.
(
- Contribution to journal › Article
-
Mark
Epithelial and Stromal MicroRNA Signatures of Columnar Cell Hyperplasia Linking Let-7c to Precancerous and Cancerous Breast Cancer Cell Proliferation.
(
- Contribution to journal › Article
- 2013
-
Mark
Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity
(
- Contribution to journal › Article
-
Mark
Low PIP4K2B Expression in Human Breast Tumors Correlates with Reduced Patient Survival: A Role for PIP4K2B in the Regulation of E-Cadherin Expression
(
- Contribution to journal › Article
- 2012
-
Mark
Low ERK Phosphorylation in Cancer-Associated Fibroblasts Is Associated with Tamoxifen Resistance in Pre-Menopausal Breast Cancer
(
- Contribution to journal › Article
-
Mark
Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration.
(
- Contribution to journal › Article
-
Mark
Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information
(
- Contribution to journal › Article
-
Mark
Med1 plays a critical role in the development of tamoxifen resistance
(
- Contribution to journal › Article
-
Mark
Genetic predisposition, parity, age at first childbirth and risk for breast cancer
(
- Contribution to journal › Article
-
Mark
The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ER alpha, and is an independent prognostic factor in node-negative breast cancer
(
- Contribution to journal › Article
- 2011
-
Mark
A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen.
(
- Contribution to journal › Article
-
Mark
Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche.
(
- Contribution to journal › Article
-
Mark
Tumour-related factors and prognosis in breast cancer detected by screening.
2011) In British Journal of Surgery(
- Contribution to journal › Article
-
Mark
Cyclin D1, Id1 and EMT in breast cancer
(
- Contribution to journal › Article
-
Mark
Stromal Expression of β-Arrestin-1 Predicts Clinical Outcome and Tamoxifen Response in Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Food sources of fat and sex hormone receptor status of invasive breast tumors in women of the malmö diet and cancer cohort.
(
- Contribution to journal › Article
-
Mark
Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancer.
(
- Contribution to journal › Article
-
Mark
Isolation and characterization of progenitor-like cells from human renal proximal tubules.
(
- Contribution to journal › Article
-
Mark
FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function
(
- Contribution to journal › Article
-
Mark
PKA-induced phosphorylation of ER alpha at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer
(
- Contribution to journal › Article
- 2010
-
Mark
Parity and age at first childbirth in relation to the risk of different breast cancer subgroups
(
- Contribution to journal › Published meeting abstract
-
Mark
Is duration of breastfeeding related to risk of different breast cancer subgroups?
(
- Contribution to journal › Published meeting abstract
-
Mark
Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.
(
- Contribution to journal › Article
-
Mark
PKC alpha expression is a marker for breast cancer aggressiveness
(
- Contribution to journal › Article
-
Mark
STROMA-DERIVED MARKERS PREDICTING BREAST CANCER PROGNOSIS AND TREATMENT RESPONSE
(
- Contribution to journal › Published meeting abstract
-
Mark
p27(Kip1) is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features.
(
- Contribution to journal › Article
-
Mark
Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
(
- Contribution to journal › Article
- 2009
-
Mark
Inactivation of the retinoblastoma tumour suppressor pathway in premenopausal breast cancer is associated with resistance to tamoxifen
(
- Contribution to journal › Published meeting abstract
-
Mark
Differential expression of cytoplasmic and stromal beta-arrestin-1 is associated with separate aspects of tumor behavior in breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
Role of p27 in tamoxifen response in breast cancer cell lines
(
- Contribution to journal › Published meeting abstract
-
Mark
Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.
(
- Contribution to journal › Article
-
Mark
WNT-5a-CKIalpha signaling promotes beta -catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells.
(
- Contribution to journal › Article
-
Mark
Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
Parity and age at first childbirth in relation to the risk of different breast cancer subgroups.
(
- Contribution to journal › Article
-
Mark
Estrogen Receptor-{alpha} Phosphorylation at Serine-118 and Tamoxifen Response in Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Extranuclear Coactivator Signaling Confers Insensitivity to Tamoxifen.
(
- Contribution to journal › Article
-
Mark
Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.
(
- Contribution to journal › Article
-
Mark
Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Parity in relation to survival following breast cancer.
(
- Contribution to journal › Article
-
Mark
Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer
(
- Contribution to journal › Article
-
Mark
The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.
(
- Contribution to journal › Article
-
Mark
Serum calcium and tumour aggressiveness in breast cancer: a prospective study of 7847 women.
(
- Contribution to journal › Article
-
Mark
Prognostic Significance of Stromal Platelet-Derived Growth Factor beta-Receptor Expression in Human Breast Cancer
(
- Contribution to journal › Article
-
Mark
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer.
(
- Contribution to journal › Article
-
Mark
JAM-A expression positively correlates with poor prognosis in breast cancer patients
(
- Contribution to journal › Article
-
Mark
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
2009) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 22. p.1564-1574(
- Contribution to journal › Article
-
Mark
Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer
(
- Contribution to journal › Article
- 2008
-
Mark
Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
Oestrogen receptor beta immunohistochemistry: time to get it right? Authors' response
(
- Contribution to journal › Letter
-
Mark
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
(
- Contribution to journal › Article
-
Mark
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
(
- Contribution to journal › Article
-
Mark
Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.
(
- Contribution to journal › Article
-
Mark
Plant foods and estrogen receptor {alpha} and {beta} defined breast cancer: observations from the Malmo Diet and Cancer cohort.
(
- Contribution to journal › Article
-
Mark
Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study
(
- Contribution to journal › Article
-
Mark
C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein in Alzheimer's disease: Binding to Abeta(1-42) and to dead cells.
(
- Contribution to journal › Article
-
Mark
HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors.
(
- Contribution to journal › Article
-
Mark
Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
(
- Contribution to journal › Article
-
Mark
Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer
(
- Contribution to journal › Article
-
Mark
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer
(
- Contribution to journal › Article
- 2007
-
Mark
Hypoxia and breast cancer: prognostic and therapeutic implications
(
- Contribution to journal › Scientific review
-
Mark
Transcriptional upregulation and unmethylation of the promoter region of p16 in invasive basal cell carcinoma cells and partial co-localization with the gamma2 chain of laminin-332.
(
- Contribution to journal › Article
-
Mark
Breast tumours following combined hormone replacement therapy express favourable prognostic factors.
(
- Contribution to journal › Article
-
Mark
Diet and body constitution in relation to sub-groups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators.
(
- Contribution to journal › Article
-
Mark
Expression of the cytoskeleton linker protein ezrin in human cancers
(
- Contribution to journal › Article
-
Mark
CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer
(
- Contribution to journal › Article
- 2006
-
Mark
Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16 in Rb-functional and Rb-inactivated tumor cells.
(
- Contribution to journal › Article
-
Mark
Cyclin e overexpression reduces infiltrative growth in breast cancer - Yet another link between proliferation control and tumor invasion
(
- Contribution to journal › Article
-
Mark
Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer
(
- Contribution to journal › Article
-
Mark
Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
(
- Contribution to journal › Article
-
Mark
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Increased expression of cyclin A1 protein is associated with all-trans retinoic acid-induced apoptosis.
(
- Contribution to journal › Article
-
Mark
MTA1, a transcriptional activator of breast cancer amplified sequence 3
(
- Contribution to journal › Article
-
Mark
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance
(
- Contribution to journal › Article
- 2005
-
Mark
Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus.
(
- Contribution to journal › Article
-
Mark
High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells.
(
- Contribution to journal › Article
-
Mark
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation.
(
- Contribution to journal › Article
-
Mark
Hypoxia-induced dedifferentiation of tumor cells - A mechanism behind heterogeneity and aggressiveness of solid tumors.
(
- Contribution to journal › Scientific review
-
Mark
Microarray-based Analyses of Hypoxia-induced Transcriptional Changes in Breast Cancer Cell Lines
(
- Contribution to journal › Article
-
Mark
Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response.
(
- Contribution to journal › Article
-
Mark
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
(
- Contribution to journal › Article
-
Mark
Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome.
(
- Contribution to journal › Article
-
Mark
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
(
- Contribution to journal › Article
-
Mark
Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.
(
- Contribution to journal › Article
-
Mark
Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression.
(
- Contribution to journal › Article
-
Mark
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.
(
- Contribution to journal › Article
-
Mark
A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells.
(
- Contribution to journal › Article
-
Mark
Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival
(
- Contribution to journal › Article
-
Mark
Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up.
(
- Contribution to journal › Article
- 2004
-
Mark
Retinoblastoma protein function and p16(INK4a) expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16(INK4a) expression and infiltrative behavior.
(
- Contribution to journal › Article
-
Mark
Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins
(
- Contribution to journal › Article
-
Mark
Erythropoietin enhances response to treatment in patients with advanced breast cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Expression of vascular endothelial growth factor protein in human renal cell carcinoma.
(
- Contribution to journal › Article
-
Mark
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells.
(
- Contribution to journal › Article
-
Mark
Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer
(
- Contribution to journal › Article
- 2003
-
Mark
Lower molecular weight forms of cyclin e: super activators of the cell cycle?
(
- Contribution to journal › Article
-
Mark
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray
(
- Contribution to journal › Article
-
Mark
Invade or Proliferate? Two Contrasting Events in Malignant Behavior Governed by p16(INK4a) and an Intact Rb Pathway Illustrated by a Model System of Basal Cell Carcinoma.
(
- Contribution to journal › Article
-
Mark
C-erbB2, p27 and G1/S aberrations in human primary breast cancer
(
- Contribution to journal › Article
-
Mark
The breast cancer-associated gene Di12 has oncogenic activity
(
- Contribution to journal › Article
-
Mark
Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of ductal carcinomas in situ and invasive breast tumors
(
- Contribution to journal › Article
-
Mark
Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer
(
- Contribution to journal › Article
-
Mark
Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-alpha expression in human breast cancer.
(
- Contribution to journal › Article
-
Mark
Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas.
(
- Contribution to journal › Article
-
Mark
Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
(
- Contribution to journal › Article
-
Mark
The RING-H2 protein RNF11 is differentially expressed in breast tumours and interacts with HECT-type E3 ligases
(
- Contribution to journal › Article
- 2002
-
Mark
Multiparameter analyses of cell cycle regulatory proteins in human breast cancer: a key to definition of separate pathways in tumorigenesis.
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters
(
- Contribution to journal › Article
-
Mark
Cyclin E and P27 protein content in human renal cell carcinoma: Clinical outcome and associations with cyclin D
(
- Contribution to journal › Article
-
Mark
The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node
(
- Contribution to journal › Article